Showing results (1-10 of 241) with videos related to
Sort By:
Pageof 25
Antiviral Therapy|June 26, 2008
Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversiesRobert W Shafer, Soo-Yon Rhee, Diane E BennettScientific Data|August 1, 2018
Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequencesSoo-Yon Rhee, Robert W ShaferAIDS Research and Human Retroviruses|July 19, 2019
Amino Acid Prevalence of HIV-1 pol Mutations by Direct Polymerase Chain Reaction and Single Genome SequencingPhilip L Tzou, Soo-Yon Rhee, Robert W ShaferAIDS Research and Human Retroviruses|March 8, 2021
Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive PersonsAlexander J Bailey, Soo-Yon Rhee, Robert W ShaferViruses|June 2, 2021
Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug ResistanceSoo-Yon Rhee, Philip L Tzou, Robert W ShaferJournal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assaysJie Zhang, Soo-Yon Rhee, Jonathan Taylor, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Knowledge integration of software for HIV drug resistance researchGenaro Hernandez, Soo-Yon Rhee, Robert W Shafer, et al.The Journal of Antimicrobial Chemotherapy|May 14, 2010
Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutationsElizabeth C Reuman, Soo-Yon Rhee, Susan P Holmes, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Prediction of HIV mutation changes based on treatment historyRay S Lin, Soo-Yon Rhee, Robert W Shafer, et al.Viruses|February 16, 2016
Genetic Variability of HIV-1 for Drug Resistance Assay DevelopmentDana S Clutter, Patricia Rojas Sánchez, Soo-Yon Rhee, et al.Pageof 25